Navigation Links
Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
Date:4/9/2013

errors and speeds up the overall trial process, reducing clinical research costs by up to 20%.
Despite the benefits, adoption of EDC systems has remained slow. By December 2012, only 40% of Phase I clinical trials utilized EDC. How can these low adoption rates be explained? Do the currently-available EDC systems effectively meet sponsor companies’ needs?

Event details:
Wednesday, April 17, 2013
5.30pm – 8.00pm PDT

Onyx Pharmaceuticals
249 East Grand Avenue
South San Francisco, California 94080

Register for free before April 12, 2013: clinovo.com/biotalks

Click here to read panelists' bios

  •     Eric Morrie, Manager, Clinical Programming at Onyx Pharmaceuticals
  •     Dr. Omar Dawood, M.D., M.P.H., Visionary Senior Executive and Clinical Leader
  •     Marc Desgrousilliers, Chief Technology Officer at Clinovo
  •     Moderated by Dr. Bob Molinari, Ph.D., C.E.O. at Retrotope & Partner at MedStars

About the Silicon Valley BioTalks
The Silicon Valley BioTalks is a quarterly series of free panel discussions, sponsored by Clinovo, for life science professionals looking to streamline their clinical trials. Representatives from leading pharmaceutical, biotechnology, and medical device companies share expertise and best practices about hot topics in the industry.
Read about the latest sessions on clinovo.com/biotalks

Read the full story at http://www.prweb.com/releases/2013/4/prweb10613870.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Galectin Therapeutics: Turning Atlanta into Americas Next Silicon Valley
2. Building quantum states with individual silicon atoms
3. New material interface improves functioning of non-silicon-based electronic devices
4. New world record efficiency for thin film silicon solar cells
5. Bluestar Silicones Presents Soft Silicone Advantages At Medical Design And Manufacturing (MD&M) West Show
6. Rigaku Publishes Application Note for Accurate Quantitative Analysis of Ferrosilicon by the Fusion Method Using ZSX Primus III+
7. Tiny compound semiconductor transistor could challenge silicons dominance
8. Flexible silicon solar-cell fabrics may soon become possible
9. Fabrication on patterned silicon carbide produces bandgap to advance graphene electronics
10. Rice team boosts silicon-based batteries
11. Aviir Diagnostic Laboratories Secures $8 Million In Funding From Silicon Valley Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... -- Smith & Nephew (LSE:SN, NYSE: SNN ... its entry into the forefoot market with the ... Comprised of three separate repair options, the HAT-TRICK ... and reconstruction, a metatarsal osteotomy guide, and a ... also known as hammer toe correction. ...
(Date:7/31/2014)... July 31, 2014 The global market ... million by 2020, according to a new study by ... and theranostics, and the subsequent introduction of advanced cancer ... market growth over the next six years. Moreover, the ... such as cancer, coupled with disease triggering lifestyle habits ...
(Date:7/31/2014)... 31, 2014 SoundConnect , ... company, is proud to announce the addition of ... Adobe Connect’s elearning tools to quickly deploy and ... with training tools for desktop and mobile learning ... is the perfect online training solution, enabling organizations ...
(Date:7/30/2014)... JOLLA, Calif. , July 30, 2014 ... ), a biopharmaceutical company leading the discovery and development ... will report financial results and highlights for the quarter ... after the U.S. financial markets close. ... Wednesday, August 6, 2014, at 5:00 pm Eastern Daylight ...
Breaking Biology Technology:Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 2Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 3Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 5SoundConnect Enhances Portfolio with Adobe Connect Learning Management System (LMS) 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... Computing researchers at Houston,s Rice University and electronics ... announced the formation of a $2.6-million Institute for ... at 4 million Singapore dollars, aims to slash ... -- special-purpose computer chips that power everything from ...
... Presented at the 12th World Conference on Lung ... 4 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: YMI ... that identifies,develops and commercializes differentiated products for patients ... two cohorts of,the Phase I part of a ...
... 4 The Cytokine Institute (TCI), a Los,Angeles-based ... the opening of a new office in the ... measures and analyzes the effects of,chemical and toxic ... Boston-based consulting arm, Green Reach Consulting, TCI now ...
Cached Biology Technology:Rice, Nanyang Tech collaborate on sustainable nanoelectronics 2Rice, Nanyang Tech collaborate on sustainable nanoelectronics 3YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 2YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 3YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 4YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION 5Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases 2
(Date:7/31/2014)... make a rational choice to be liberal or conservative? ... a matter of genetics?, Two political scientists from the ... say that neither conscious decision-making nor parental upbringing fully ... right. , A growing body of evidence shows that ... of political differences, the researchers say in the latest ...
(Date:7/31/2014)... the U.S. surgeon general issued a 101-page report about ... University published a paper breaking new ground on how ... responds when exposed to ultraviolet (UV) light. , The ... UV rays found in sunlight. This damage can lead ... , "Our paper advances foundational knowledge about how ...
(Date:7/31/2014)... Florida State University researcher found that bacteria in the ... of the oil released during the Deepwater Horizon spill ... most toxic contaminants. , In two new studies conducted ... found a species of bacteria called Colwellia ... and xylene compounds that were released as part of ...
Breaking Biology News(10 mins):Scientists find growing consensus: Political attitudes derive from body and mind 2New paper describes how DNA avoids damage from UV light 2New paper describes how DNA avoids damage from UV light 3
... This press release is available in French ... a whole lot safer for consumers, thanks to Concordia University ... substances in dairy and other products. "Even though Canada ... antibiotics in cows, until now there were no methods or ...
... basic research, Dr. Peter W. Schiller, a world-renowned peptide chemist ... at the Institut de recherches cliniques de Montral (IRCM), and ... patents awarded to the institute and covering different uses of ... Schiller,s laboratory at the IRCM. A total of ...
... OAK RIDGE, Tenn. -- A tree outside Oak Ridge ... inspiration for a discovery that may ultimately lead to ... more. Just as a breeze causes leaves, branches ... the molecular level perform hundreds of chemical processes that ...
Cached Biology News:Discovery of therapeutic peptides affecting mitochondria 2ORNL fundamental discovery casts enzymes in new light 2
RNA polymerase sigma 70 Immunogen: Recombinant, full length protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Anti-Dardarin Immunogen: Synthetic peptide from rat LRRK2. Available Date: 38814...
Rat monoclonal to UGGT ( Abpromise for all tested applications)....
... Rabbit polyclonal to MSY2/YBOX2 ( Abpromise ... Antigen: Synthetic peptide ... the C-terminus of Human MSY2/YBOX2. ... proprietary) (Peptide available ...
Biology Products: